These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10771385)

  • 1. Leucodepletion monitoring by flow cytometry (Becton-Dickinson): from universal to statistical process monitoring.
    Barclay R; McColl K; Walker B
    Transfus Sci; 2000; 22(1-2):63-4. PubMed ID: 10771385
    [No Abstract]   [Full Text] [Related]  

  • 2. National evaluation of IMAGN 2000 for quality monitoring of leucodepleted red cell and platelet concentrates: comparison with flow and Nageotte.
    Seghatchian J; Krailadsiri P; Chandegra B; Beard M; Beckman N; Bissett L; Morris B; Booker W
    Transfus Sci; 2000; 22(1-2):77-9. PubMed ID: 10771390
    [No Abstract]   [Full Text] [Related]  

  • 3. Factors influencing the outcome of leucodepletion system.
    Seghatchian J; Krailadsiri P
    Transfus Sci; 2000; 22(1-2):135-7. PubMed ID: 10771402
    [No Abstract]   [Full Text] [Related]  

  • 4. The UK strategy for monitoring universal leucodepletion.
    Beckman N; Seghatchian J
    Transfus Sci; 1999 Oct; 21(2):147-51. PubMed ID: 10747523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring universal leucodepletion performance: the current issues within components production and testing.
    Beckman N; Seghatchian J
    Transfus Apher Sci; 2001 Jun; 24(3):233-6. PubMed ID: 11791692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of different enrichment strategies for analysis of leucocyte sub-populations: development and application of a new approach, based on leucofiltration.
    Seghatchian J; Krailadsiri P
    Transfus Apher Sci; 2002 Feb; 26(1):61-72. PubMed ID: 11931379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic RBC leucodepletion in France: where are we after six months?
    Masse M
    Transfus Sci; 2000; 22(1-2):57-9. PubMed ID: 10771383
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluating leucodepletion systems suitable for routine use.
    Rowe G
    Transfus Sci; 2000; 22(1-2):61-2. PubMed ID: 10771384
    [No Abstract]   [Full Text] [Related]  

  • 9. Selective or universal leucodepletion: the Italian experience.
    Accorsi P; Iacone A
    Transfus Sci; 2000; 22(1-2):65-7. PubMed ID: 10771386
    [No Abstract]   [Full Text] [Related]  

  • 10. [Current data on the counting of weak leukocyte concentrations in labile blood products].
    Masse M
    Transfus Clin Biol; 1995; 2(5):365-72. PubMed ID: 8581179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of a national standardized approach for the enumeration of residual leucocytes in blood components.
    Cardigan R; Phipps A; Seghatchian J; Bashir S; Aynsley S; Beckman N; Barnett D; Reilly JT; Williamson LM
    Vox Sang; 2002 Aug; 83(2):100-9. PubMed ID: 12201839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. nvCJD and leucodepletion: an overview.
    Seghatchian J
    Transfus Sci; 2000; 22(1-2):47-8. PubMed ID: 10771379
    [No Abstract]   [Full Text] [Related]  

  • 13. Low level leucocyte counting (LLLC) in blood products.
    Brando B; Barnett D; Arroz MJ
    J Biol Regul Homeost Agents; 2003; 17(3):234-40. PubMed ID: 14524608
    [No Abstract]   [Full Text] [Related]  

  • 14. A simple flow-cytometric method for absolute counting of residual white blood cells in leukocyte-reduced packed red cells.
    Gómez-Arbonés X; Pinacho A; Ortiz P; Maciá J; Gallart M; Araguás C; Sánchez JM; Teixidó M
    Vox Sang; 1999; 76(1):64-5. PubMed ID: 9933857
    [No Abstract]   [Full Text] [Related]  

  • 15. Flow cytometric determination of residual leucocytes in filter-depleted blood products: an evaluation of Becton-Dickinson's LeucoCOUNT system.
    Barclay R; Walker B; Allan R; Reid C; Duffin E; Kane E; Turner M
    Transfus Sci; 1998 Dec; 19(4):399-403. PubMed ID: 10351167
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the characterisation of the cause of leucoreduction failures, with particular reference to extra gatal events.
    Seghatchian J; Krailadsiri P; Beard M; Bukasa A; Bashir S
    Transfus Apher Sci; 2002 Feb; 26(1):47-60. PubMed ID: 11931378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leucodepletion and regulatory aspects in Germany.
    Heiden M; Keller-Stanislawski B
    Transfus Sci; 2000; 22(1-2):69-70. PubMed ID: 10771387
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of flow cytometry vs. a haematology cell analyser-based method to guide the optimal time-point for peripheral blood stem cell apheresis.
    Gutensohn K; Magens M; Krüger W; Kröger N; Kühnl P
    Vox Sang; 2006 Jan; 90(1):53-8. PubMed ID: 16359356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of whole-blood conservation reagents for Hematoflow-based WBC differential count: Unsatisfactory results.
    Wagner-Ballon O; Badaoui B; Brignoli A; Le Priol J; Roussel M
    Int J Lab Hematol; 2017 Oct; 39(5):e127-e131. PubMed ID: 28656600
    [No Abstract]   [Full Text] [Related]  

  • 20. Flow cytometry: the standard for monitoring the onset of apheresis and for the evaluation of stem and progenitor cell graft quality.
    Gutensohn K; Magens MM; Kuehnl P
    Vox Sang; 2000; 78 Suppl 2():131-5. PubMed ID: 10938942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.